Literature DB >> 32063436

Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation.

Annalisa Colaprico1, Silvia Senesi2, Francesca Ferlicca2, Brunella Brunelli2, Mildred Ugozzoli3, Michele Pallaoro3, Derek T O'Hagan2.   

Abstract

Aluminum based adjuvants are widely used in commercial vaccines, since they are known to be safe and effective with a variety of antigens. The effect of antigen adsorption onto Aluminum Hydroxide is a complex area, since several mechanisms are involved simultaneously, whose impact is both antigen and formulation conditions dependent. Moreover, the mode of action of Aluminum Hydroxide is itself complex, with many mechanisms operating simultaneously. Within the literature there are contrasting theories regarding the effect of adsorption on antigen integrity and stability, with reports of antigen being stabilized by adsorption onto Aluminum Hydroxide, but also with contrary reports of antigen being destabilized. With the aim to understand the impact of adsorption on three recombinant proteins which, following in vivo immunization, are able to induce functional bactericidal antibodies against Neisseria meningitidis type B, we used a range of physico-chemical tools, such as DSC and UPLC, along with in vitro binding of antibodies that recognize structural elements of the proteins, and supported the in vitro data with in vivo evaluation in mice studies. We showed that, following exposure to accelerated degradation conditions involving heat, the recombinant proteins, although robust, were stabilized by adsorption onto Aluminum Hydroxide and retain their structural integrity unlike the not adsorbed proteins. The measure of the Melting Temperature was a useful tool to compare the behavior of proteins adsorbed and not adsorbed on Aluminum Hydroxide and to predict protein stability.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aluminum hydroxide; Antigen adsorption; Calorimetry; Neisseria meningitidis type B; Vaccine; capture ELISA

Mesh:

Substances:

Year:  2020        PMID: 32063436     DOI: 10.1016/j.vaccine.2020.02.001

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Role of site-directed mutagenesis and adjuvants in the stability and potency of anthrax protective antigen.

Authors:  Mohammed Ali Dahhas; Mohammad A Alsenaidy
Journal:  Saudi Pharm J       Date:  2022-02-25       Impact factor: 4.562

2.  Efficient antigen cross-presentation through coating conventional aluminum adjuvant particles with PEI.

Authors:  Hongyan Ren; Yongbin Mou; Lin Lin; Lixin Wang; Hongming Hu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice.

Authors:  Katharina Wørzner; Daniel J Sheward; Signe Tandrup Schmidt; Leo Hanke; Julie Zimmermann; Gerald McInerney; Gunilla B Karlsson Hedestam; Ben Murrell; Dennis Christensen; Gabriel Kristian Pedersen
Journal:  EBioMedicine       Date:  2021-01-07       Impact factor: 8.143

4.  Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy.

Authors:  Mingxia Jiang; Liping Zhao; Xiaoming Cui; Xinghan Wu; Yuhan Zhang; Xiuwen Guan; Jinlong Ma; Weifen Zhang
Journal:  J Adv Res       Date:  2021-08-19       Impact factor: 10.479

5.  Improved Aluminum Adjuvants Eliciting Stronger Immune Response When Mixed with Hepatitis B Virus Surface Antigens.

Authors:  Zhibiao Wang; Shuxiang Li; Pu Shan; Duoqian Wei; Shaojie Hao; Zhuan Zhang; Jing Xu
Journal:  ACS Omega       Date:  2022-09-15

6.  Morphology and protein adsorption of aluminum phosphate and aluminum hydroxide and their potential catalytic function in the synthesis of polymeric emulsifiers.

Authors:  Yu-Jhen Cheng; Chiung-Yi Huang; Hui-Min Ho; Ming-Hsi Huang
Journal:  Colloids Surf A Physicochem Eng Asp       Date:  2020-09-10       Impact factor: 4.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.